MainboardGMP
LIVE
LIVE GMP
Watrana Rentals Ltd₹0·Crystal Crop Protection Ltd₹+45·Vedant Poly Fabs Ltd₹0·Johnsoncab Electricals Ltd₹+5·HGS (India) Ltd₹+38·Vectras Enprocon Ltd₹0·Maxwell Engineering Solutions Ltd₹+82·Antala Industries Ltd₹0·Bombay Coated & Special Steels Ltd₹+8·Carver Roboweld Ltd₹0·Ajwa Projects Ltd₹0·M.K.Sons Fine Jewels Ltd₹+3·Watrana Rentals Ltd₹0·Crystal Crop Protection Ltd₹+45·Vedant Poly Fabs Ltd₹0·Johnsoncab Electricals Ltd₹+5·HGS (India) Ltd₹+38·Vectras Enprocon Ltd₹0·Maxwell Engineering Solutions Ltd₹+82·Antala Industries Ltd₹0·Bombay Coated & Special Steels Ltd₹+8·Carver Roboweld Ltd₹0·Ajwa Projects Ltd₹0·M.K.Sons Fine Jewels Ltd₹+3·
Home › IPOs › Vaishali Pharma Ltd.
VA
Vaishali Pharma Ltd.
CLOSED NSE SME Bookbuilding IPO Fresh Capital Vaishali Pharma IPO GMP
GREY MARKET PREMIUM
₹ 0
No premium data
EST. LISTING PRICE
₹72
Issue Price: ₹ 72
Issue Price
₹72
Face Value
₹10
Lot Size
1,600 shares
Open Date
07 Aug 2017
Close Date
10 Aug 2017
Listing Date
22 Aug 2017
Exchange
NSE SME
Vaishali Pharma IPO About the Company
...read more
Vaishali Pharma IPO Objects of the Issue
Purpose Amount (₹ Cr)
Working Capital Requirement ₹13
Vaishali Pharma IPO Lead Managers
Pantomath Capital Advisors Pvt.Ltd
Financial Summary Amount in Rs Cr
Metric 31-Mar-17 31-Mar-16 31-Mar-15
Total Assets 4,465 4,941 4,580
Revenue 6,711 6,989 9,882
PAT 66 3 16
Issue Details
Total Shares Offered
1,976,000 (100%)
Reserved for Market Maker
Up to ₹1 Cr
Net Offer to Public
Up to ₹13 Cr
Pre-Issue Shareholding
4,615,385 shares
Post-Issue Shareholding
6,591,385 shares
UPI Mandate
10 Aug 2017
IPO Analytics Dashboard
LIVE
Vaishali Pharma IPO GMP Insights
👤
Retail Demand
Strong
💼
HNI Interest
Strong
📊
Valuation
Moderate
Vaishali Pharma IPO GMP Strength Score
8 / 10 Strong
0–3 Weak 3–6 Moderate 6–8 Good 8–10 Strong
Vaishali Pharma IPO Category-wise Subscription Shares offered, bid & amount
Category Sub (x) Offered Bid For
💼 NII / HNI — 936,000 (47%) —
👤 Retail (RII) — 936,000 (47%) —
📊 Market Maker — 104,000 (5%) —
Σ Total — 1,976,000 (100%) —

* Amount calculated at upper price band (₹72) ·  ** Total includes all investor categories

Subscription Overview Share allocation by investor category
💼
NII / HNI ? 936,000 (47%)
47%
👤
Retail (RII) ? 936,000 (47%)
47%
📊
Market Maker ? 104,000 (5%)
5%
Total Shares Offered 1,976,000 (100%)
Vaishali Pharma IPO Application Sizing Minimum investment by category
👤 Retail Investors ?
Min. Lots 1
Shares / Lot 1,600
Min. Investment ₹115,200
💼 HNI Investors ?
Min. Lots 2
Min. Shares 3,200
Min. Investment ₹230,400
Investor Interpretation
  • Retail allocation is strong at 47% of the total offering.
  • HNI/NII demand is strong at 47%.

This IPO shows strong fundamentals and healthy investor demand. Research the business model and compare with sector peers before applying.

STOCK PRICE HISTORY  ·  NSE
—
Issue Price: ₹ 72  ·  Symbol: —
H —
L —
O —
Vaishali Pharma IPO Company Info
📍 706 to 709 7th Floor, Aravali Business Centre, Borivali(W) , Mumbai, Maharashtra, 400092
Visit Website
Vaishali Pharma IPO Registrar
Bigshare Services Pvt.Ltd
Check Allotment Status
Vaishali Pharma IPO FAQs
Vaishali Pharma IPO has already listed. Its last recorded GMP was ₹0. GMP is only indicative and never a guarantee of listing gains.
The issue price of Vaishali Pharma IPO is ₹72 per share. One lot has 1,600 shares, so the minimum investment is about ₹115,200. It is a Fresh Capital issue.
Vaishali Pharma IPO opened on 07 Aug 2017 and closed on 10 Aug 2017. Shares are listed on NSE SME on 22 Aug 2017.
As per the offer document, Vaishali Pharma plans to use the IPO proceeds for: Working Capital Requirement (₹13).
The lead manager of Vaishali Pharma IPO is Pantomath Capital Advisors Pvt.Ltd.
Vaishali Pharma IPO is proposed to list on NSE SME; it is a Bookbuilding IPO and the issue is a Fresh Capital.
Disclaimer

The information on mainboardgmp.com is provided for educational and informational purposes only.

We are not a Securities and Exchange Board of India (SEBI)-registered investment advisor, analyst, broker, or financial planner. The content, data, and insights on this website, including Grey Market Premium (GMP), subscription data, IPO dates, and market information, are not intended as financial advice or recommendations to buy, sell, or hold securities.

GMP and related IPO data are collected from unofficial market sources and may not reflect actual IPO listing performance or future price movements. You should not rely solely on the information provided here to make financial or investment decisions.

Investing in IPOs and securities involves risk. Always conduct your own research and consult a qualified SEBI-registered financial advisor before making investment decisions. mainboardgmp.com and its owners shall not be liable for any financial losses, trading losses, or damages arising from use of this website.

By using this website, you acknowledge and agree that you use the content at your own risk.